These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6286196)

  • 1. Sera from breast cancer patients contain an IgA antibody to a breast cyst fluid component.
    Witkin SS; Richards JM; Bongiovanni AM; Breed CN; Day NK
    Clin Immunol Immunopathol; 1982 May; 23(2):358-65. PubMed ID: 6286196
    [No Abstract]   [Full Text] [Related]  

  • 2. Antigens and antibodies cross-reactive to the murine mammary tumor virus in human breast cyst fluids.
    Witkin SS; Sarkar NH; Kinne DW; Breed CN; Good RA; Day NK
    J Clin Invest; 1981 Jan; 67(1):216-22. PubMed ID: 6256413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [B cells and serum immunoglobulins in patients with breast pathology].
    Zornoza G; Hernández JL; Sanz ML; Fernández J; Goena I; Lera JM
    Rev Esp Oncol; 1981; 28(1):17-27. PubMed ID: 6984973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies reactive with the mouse mammary tumor virus in sera of breast cancer patients.
    Witkin SS; Sarkar NH; Kinne DW; Good RA; Day NK
    Int J Cancer; 1980 Jun; 25(6):721-5. PubMed ID: 14768700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin levels in breast cyst fluid: apparent connection with intracystic transcortin (CBG) binding activity.
    Agrimonti F; Cavallo R; Frairia R; Violino PL; Borretta G; Angeli A
    Boll Ist Sieroter Milan; 1982 Mar; 61(1):44-50. PubMed ID: 6812601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased incidence of mouse mammary tumor virus-related antigen in Tunisian patients with breast cancer.
    Levine PH; Mesa-Tejada R; Keydar I; Tabbane F; Spiegelman S; Mourali N
    Int J Cancer; 1984 Mar; 33(3):305-8. PubMed ID: 6321360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunological cross reaction between human breast cancer and mammopathy and virus-producing breast carcinomas of the mouse].
    Müller M; Zotter S; Grossmann H; Kemmer C
    Arch Geschwulstforsch; 1972; 40(4):285-99. PubMed ID: 4346686
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cross reaction between human breast cancer, mastopathy and murine mamma carcinoma: localization of the antigen in type-A-particle-virus].
    Müller M; Kemmer C; Zotter S; Grobbman H; Micheel B
    Arch Geschwulstforsch; 1973; 41(2):100-6. PubMed ID: 4354922
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma immunoglobulin levels in patients with breast cancer.
    Wang DY; Goodwin PR; Bulbrook RD; Hayward JL
    Cancer; 1977 May; 39(5):2190-3. PubMed ID: 858130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte inhibition by mammary tumor virus in patients with breast cancer.
    Moulton A; Gerfo PL; Suciu-Foca N; Silverstein G
    J Surg Res; 1974 Jun; 16(6):592-8. PubMed ID: 4366357
    [No Abstract]   [Full Text] [Related]  

  • 11. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells.
    McCoy JL; Tagliabue A; Ames RE; Teramoto YA; Cannon GB; Alford C; Herberman RB; Schlom J
    J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localisation of Ca and HMFG2 antigens in breast tissue by immunoperoxidase, immunofluorescence, and immunoelectron microscopy.
    Beckford U; Barbatis C; Beesley JE; Linsell JC; Chantler SM
    J Clin Pathol; 1985 May; 38(5):512-20. PubMed ID: 3889068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to mouse mammary tumor virus-related antigen in sera of patients with breast carcinoma.
    Tomana M; Kajdos AH; Niedermeier W; Durkin WJ; Mestecky J
    Cancer; 1981 Jun; 47(11):2696-703. PubMed ID: 6266639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunoassay for glycoprotein gp47 of murine mammary tumor virus in organs and serum of mice and search for related antigens in human sera.
    Zangerie PF; Calberg-Bacq CM; Colin C; Franchimont P; François C; Gosselin L; Kozma S; Osterrieth PM
    Cancer Res; 1977 Dec; 37(12):4326-31. PubMed ID: 200346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin levels in breast fluids of women with breast cancer.
    Petrakis NL; Doherty M; Lee R; Mason L; Pawson S; Hunt TK; Schweitzer R
    Clin Immunol Immunopathol; 1977 May; 7(3):386-93. PubMed ID: 872460
    [No Abstract]   [Full Text] [Related]  

  • 16. Human lymphocyte blastogenesis responses to mouse mammary tumor virus.
    Wiseman CL; Bowen JM; Davis JW; Hersh EM; Brown BW; Blumenschein GR
    J Natl Cancer Inst; 1980 Mar; 64(3):425-30. PubMed ID: 6243719
    [No Abstract]   [Full Text] [Related]  

  • 17. [Distribution of so-called Thomsen-Friedenreich antigens in normal, diseased and carcinomatous breast tissue].
    Klein PJ; Newman RA; Müller P; Schaefer HE; Lennartz KJ; Uhlenbruck G; Fischer R
    Verh Dtsch Ges Pathol; 1978; 62():325. PubMed ID: 746856
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum antibody in patients with breast disease: Correlation with histopathology.
    Humphrey LJ; Estes NC; Morse PA; Jewell WR; Boudet RA; Hudson MJ; Tsolakidis PG; Mantz FA
    Ann Surg; 1974 Jul; 180(1):124-9. PubMed ID: 4209818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating breast tumour antigen-sensitive T lymphocytes in early breast cancer and high risk benign breast disease.
    Ramey WG; Hashim GA; Fitzpatrick HF
    Br J Surg; 1979 Dec; 66(12):848-52. PubMed ID: 315807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards an idiotype vaccine against mammary tumors. Induction of an immune response to breast cancer-associated antigens by anti-idiotypic antibodies.
    Smorodinsky NI; Ghendler Y; Bakimer R; Chaitchuk S; Keydar I; Shoenfeld Y
    Eur J Immunol; 1988 Nov; 18(11):1713-8. PubMed ID: 2849550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.